SC
IMVT icon

Steven Cohen’s Immunovant IMVT Stock Holding History

Steven Cohen’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,000,000
Closed -$50.8M – 4123
2025
Q4 		$50.8M Sell
2,000,000
-1,442,078
-42% -$32.2M 0.06% 400
2025
Q3 		$55.5M Buy
3,442,078
+105,828
+3% +$1.71M 0.09% 248
2025
Q2 		$53.4M Buy
3,336,250
+2,534,323
+316% +$38.3M 0.1% 240
2025
Q1 		$13.7M Buy
+801,927
New +$16.8M 0.03% 567
2024
Q2 		– Sell
-1,383,810
Closed -$44.7M – 2129
2024
Q1 		$44.7M Sell
1,383,810
-1,283,073
-48% -$46.8M 0.11% 227
2023
Q4 		$112M Buy
+2,666,883
New +$98.1M 0.27% 76
2023
Q3 		– Sell
-457,467
Closed -$8.68M – 2656
2023
Q2 		$8.68M Buy
+457,467
New +$8.53M 0.03% 633
2023
Q1 		– Sell
-435,751
Closed -$7.73M – 2384
2022
Q4 		$7.73M Sell
435,751
-1,531,549
-78% -$19.3M 0.03% 631
2022
Q3 		$11M Buy
+1,967,300
New +$9.62M 0.04% 482
2022
Q2 		– Sell
-459,300
Closed -$2.53M – 1501
2022
Q1 		$2.53M Sell
459,300
-441,200
-49% -$2.75M 0.01% 836
2021
Q4 		$7.67M Buy
+900,500
New +$7.43M 0.03% 580
2021
Q2 		– Sell
-187,900
Closed -$3.01M – 1063
2021
Q1 		$3.01M Sell
187,900
-70,500
-27% -$1.86M 0.01% 670
2020
Q4 		$11.9M Sell
258,400
-1,254,866
-83% -$58M 0.06% 400
2020
Q3 		$53.3M Buy
1,513,266
+1,363,623
+911% +$41M 0.27% 87
2020
Q2 		$3.64M Buy
149,643
+126,251
+540% +$2.71M 0.02% 525
2020
Q1 		$364K Buy
+23,392
New +$352K ﹤0.01% 684

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Steven Cohen's IMVT Position: Q1 2026 in Review

Steven Cohen sold out of Immunovant (IMVT) in Q1 2026, closing a stake of 2,000,000 shares — an estimated $50.8M sold.

Steven Cohen first reported a position in IMVT in Q1 2020 and held it in 16 quarters. The position peaked at $112M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Steven Cohen reported no remaining Immunovant position as of Q1 2026 after selling out during the quarter.
  • Steven Cohen sold 2,000,000 Immunovant shares in Q1 2026, an estimated $50.8M.
  • Steven Cohen first reported a position in Immunovant in Q1 2020 and held it in 16 quarters.
  • Steven Cohen's Immunovant position peaked at $112M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.